Hemant Surgical Industries Lim
BSE: HSIL · Medical Equipment & Supplies · sector
Key numbers
Last 12 months to Mar 2026, Consolidated. "Sector median" = middle value of 15 companies in Medical Equipment & Supplies (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Operating profit covered interest 7.0x in the last 12 months.
- Other income was 32% of net profit in the last 12 months.
- No dividend in the last 3 financial years.
- Price ₹567.60 on 2026-10-26: -16.4% from the 52-week high, +164.0% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Quarterly results
| ₹ cr | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|
| Revenue | 58 | 65 | 167 |
| EBITDA | 5 | 8 | 16 |
| OPM % | 9.4% | 11.8% | 9.3% |
| Other income | 3 | 2 | 4 |
| Net profit | 5 | 5 | 13 |
| EPS (₹) | 4.65 | 5.15 | 10.24 |
Consolidated figures where filed. Latest quarter Mar 2026.
Profit & loss (yearly)
| ₹ cr | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|
| Revenue | 106 | 107 | 232 | 232 |
| EBITDA | 10 | 9 | 23 | 23 |
| Net profit | 10 | 8 | 18 | 18 |
| EPS (₹) | 9.85 | 7.70 | 15.39 | 15.39 |
| Revenue growth | +1.0% | +117.4% | – | |
| Profit growth | -18.0% | +126.2% | – | |
| Dividend / share (₹) | – | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | – | – | – |
| Net profit | – | – | – |
| EPS | – | – | – |
| Share price | – | +104.6% (2y) | +102.7% |
Balance sheet
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Shareholders' equity | 53 | 114 |
| Cash & equivalents | 10 | 44 |
| Total assets | 148 | 274 |
| Fixed assets | 40 | 53 |
| Investments | 1 | 0 |
| Inventory | 43 | 59 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Cash from operations | 9 | -32 |
| Cash from investing | -30 | -3 |
| Cash from financing | 18 | 69 |
| Capex | 38 | 2 |
| Free cash flow | -29 | -34 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY25 | FY26 |
|---|---|---|
| ROE % | 15.2% | 15.9% |
| ROCE % | 24.0% | 24.1% |
| Inventory days | 208 | 121 |
| Working capital days | 94 | 93 |
Peers in Medical Equipment & Supplies
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| POLYMED | ₹14,631 cr | 46.4x | 4.7x | 10.7% | 12.7% | 22.8% | +18.9% | 0.24% |
| MOLBIO | ₹14,360 cr | – | – | – | – | – | – | – |
| TARSONS | ₹1,587 cr | 142.7x | 2.5x | 1.8% | 4.1% | 26.8% | +14.3% | – |
| LAXMIDENTL | ₹945 cr | 30.4x | 3.9x | 13.7% | 13.4% | 14.0% | – | – |
| FISCHER | ₹856 cr | 11.2x | 2.2x | -0.8% | 11.6% | 13.6% | – | 0.04% |
| HSIL | ₹740 cr | 36.9x | 6.5x | 21.8% | 24.1% | 10.0% | – | – |
| FABTECH | ₹543 cr | 8.8x | 1.3x | 11.6% | 13.6% | 10.9% | – | – |
| PREVEST | ₹455 cr | 14.7x | 4.0x | 29.9% | 36.9% | 34.1% | +12.9% | 0.26% |
| NURECA | ₹296 cr | 63.0x | 1.6x | 2.5% | 5.3% | 3.5% | +9.7% | – |
| CHOKSI | ₹115 cr | 22.2x | 2.7x | 13.1% | 17.9% | 14.5% | +300.1% | – |
Documents
Links go to the original files on the exchange website.
About the company
| Sector | Healthcare |
| Industry | Medical Equipment & Supplies |
| Sub-industry | Medical Equipment & Supplies |
| Symbol | HSIL |
| BSE code | 543916 |
| ISIN | INE0GYI01028 |
| Face value | ₹10.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-23 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.